GlenRock Israel
About Us Investments Added Value Services Management Venture Partners Community Responsibility Contact Us
 Overview
 Life Sciences
 Technologies
 Private Equity
 Investment
 Vehicles Initiation
Investments - Private Equity
An Aggressive Leveraged Acquisition Strategy…

Together with the company's international and local partners, GlenRock identifies and pursues leveraged acquisitions of undervalued enterprises in a wide variety of fields that meet our stringent financial, market and managerial criteria.

…Focused on Creating Added Value

GlenRock believes that a great amount of value is created during the acquisition process. By recognizing the undervalued asset, negotiating “win-win” investment terms, and designing transactions that take advantage of innovative capital structures, GlenRock sets the stage for the overall success of the acquisition.

GlenRock's Private Equity Vehicles…


Mivtach Shamir
Mivtach Shamir is a publicly-traded company, headed by Mr. Meir Shamir. The company focuses on investments in companies that have encountered difficulties, with the aim of leading them to turnaround, and controlling value for shareholders. Within the Mivtach Shamir portfolio, are prominent companies like Tnuva, Lipman (sold to Verifone), Tefron, Gilat and more.
Latest News (12/2016): China's Bright Food bought control of Tnuva, the deal was valued at ~$2.5B. Mivtach posted a gain of ~ $300M from the deal.
FIMI
Founded in 1997, FIMI is Israel's first dedicated mezzanine and buy-out fund managing over $1B. Benefiting from its extensive financial capabilities and the exceptional experience of its powerful management team.
FIMI's focused investment strategy targets Israeli and Israeli related companies with proven track records of revenues, positive cash flow and significant profitability.
Key to FIMI's successful investment strategy is its smart diversification over a variety of carefully selected business sectors including computer software, consumer electronics, communications, automotive, plastics, textiles, metals, water purification and food.
Latest News (12/2016): The fund is distributing proceeds from realizations and has raised its $1.1B sixth fund.
http://www.fimi.co.il
Shavit Capital Fund
Shavit Capital Fund is a fund aimed to create high returns for investors by buying and investing in equity-related securities mainly in later stage/mezzanine rounds, where plans for an IPO or any other form of exit are reasonably demonstrated, and in IPOs and secondary/PIPE offerings.
The fund's most notable investments (and exits) were in Kamada, Superderivatives and Brainsway.
Latest News (12/2016): The second fund, Shavit Capital Fund II, which raised $25M invested in Rewalk (NASDAQ: RWLK), Foamix (NASDAQ: FOMX) Mapi Pharma and Intec Pharma (TASE:INTP). The fund launched its third and fourth funds, Shavit Capital Fund III and IV which raised $100M and have invested so far in Mapi Pharma and Polypid.
http://www.shavitcapital.com
Infinity Israel-China Fund
In March 2010, Infinity Israel-China Fund announced the establishment of six new joint private equity funds throughout China bringing total funds raised by the Fund to $420M. Infinity Israel-China Fund utilizes Infinity’s experience and partnerships in China and Infinity’s access to proven Israeli technologies to add value to the fund’s portfolio companies in both China and Israel. This is achieved by collaborating with the fund's Sponsors; GlenRock Israel and Call Industries and Investments, partnered with Suzhou Industrial Park Science & Technology Development and China-Singapore Suzhou Industrial Park Ventures Co. The fund is primarily focused on accelerating the growth of its portfolio companies by helping them meet the demand for technology based products in China. So far the Fund invested in 18 companies.
Latest News (12/2016): The company achieved a successful exit with the sale of Digital China and Wairau. Shellcase, DCITS and E.T. Xin, were listed on the Shanghai stock exchange.
http://www.infinity-vc.com